Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
WO 2025249576-A2025-12-04
CARRIER AND DRUG
Kyushu University
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
JP 2025185040-A2025-12-18
TRI-AGONIST OF THE GLP-1, GIP AND AMYLIN RECEPTORS
Applicants [Refer to the patent publication]
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
WO 2025264776-A12025-12-26
CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF
NEUROCRINE BIOSCIENCES INC
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
WO 2025264785-A12025-12-26
CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF
NEUROCRINE BIOSCIENCES INC
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
WO 2025264809-A12025-12-26
CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF
NEUROCRINE BIOSCIENCES INC
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
EP 4731244-A12026-04-29
GLP-1 ANALOG FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
SUN PHARMACEUTICAL IND LTD
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
JP 2026095374-A2026-06-10
TRI-AGONISTS OF THE GLP-1, GIP, AND AMYLIN RECEPTORS AND USES THEREOF
NOVO NORDISK A/S
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
WO 2026183390-A12026-09-03
COMPOSITIONS COMPRISING AN ANTI-ACTRII ANTIBODY, TIRZEPATIDE AND ARGININE AND USES THEREOF FOR THE TREATMENT OF OBESITY, DIABETES, METABOLIC SYNDROME, HYPERGLYCAEMIA
LILLY CO ELI
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
EP 4805505-A12026-09-16
PLASMID DNA CONSTRUCTS FOR PEPTIDE HORMONE EXPRESSION
RENBIO INC
Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 20 to 50. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||| ||| Hit 20 HGEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 5029 of 31 identical, no gaps.
-
US 5574008-A1996-11-12
Biologically active fragments of glucagon-like insulinotropic peptide
Query Match 95.0%Identity 100.0%
Best alignment
Query 2 to 31, hit 1 to 30. Positions start at 1 and include both ends.
Query 2 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||||||||||||||||| Hit 1 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3030 of 30 identical, no gaps.
-
JP 2015513544-A2015-05-14
GLP-1 PRODRUGS
Novo Nordisk A/S
Query Match 95.0%Identity 100.0%
Best alignment
Query 2 to 31, hit 1 to 30. Positions start at 1 and include both ends.
Query 2 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||||||||||||||||| Hit 1 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3030 of 30 identical, no gaps.
-
US 9452225-B22016-09-27
GLP-1 prodrugs
Novo Nordisk A/S
Query Match 95.0%Identity 100.0%
Best alignment
Query 2 to 31, hit 1 to 30. Positions start at 1 and include both ends.
Query 2 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||||||||||||||||| Hit 1 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3030 of 30 identical, no gaps.
-
KR 1020180008349-A2018-01-24
A novel ferritin nanocage whose half life is extended and use thereof
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
Query Match 95.0%Identity 100.0%
Best alignment
Query 2 to 31, hit 1 to 30. Positions start at 1 and include both ends.
Query 2 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||||||||||||||||| Hit 1 AEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3030 of 30 identical, no gaps.
-
KR 1020210081389-A2021-07-01
GLUCAGON LIKE PEPTIDE 1 (GLP1)-GROWTH DIFFERENTIATION FACTOR 15 (GDF15) FUSION PROTEINS AND USES THEREOF
JANSSEN PHARMACEUTICA N. V
Query Match 95.0%Identity 93.5%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||| ||||||| Hit 1 HSEGTFTSDVSSYLEGQAAKEFIEWLVKGRG 3129 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210081389-A2021-07-01
- EP 3870211-A12021-09-01
- JP 2022513363-A2022-02-07
-
KR 1020230079047-A2023-06-05
CONJUGATE OF FUNCTIONAL POLYPEPTIDE VARIANT, AND USE THEREOF
PROABTECH INC
Query Match 95.0%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||| ||||||||||||||||| ||| Hit 1 HAEGTFTSDXSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
US 11713345-B22023-08-01
Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof
Janssen Sciences Ireland Unlimited Company
Query Match 95.0%Identity 93.5%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||| ||||||| Hit 1 HSEGTFTSDVSSYLEGQAAKEFIEWLVKGRG 3129 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- US 11713345-B22023-08-01
- JP 2024170428-A2024-12-10
- EP 4520343-A22025-03-12
- US 12275770-B22025-04-15
-
US 7186683-A2007-03-06
Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
Sanos Bioscience A/S
Query Match 94.4%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 || ||||||||||||||||||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
US 9562910-B22017-02-07
Method for producing acylated peptides
Novo Nordisk A/S
Query Match 94.4%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||| ||||||| | | Hit 1 HAEGTFTSDVSSYLEGQAAREFIAWLVRGKG 3128 of 31 identical, no gaps.
-
JP 2020503285-A2020-01-30
Synthesis of Liraglutide
BIOCON LIMITED
Query Match 94.4%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||||||| |||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKXFIAWLVRGRG 3129 of 31 identical, no gaps.
-
WO 2020074583-A12020-04-16
PROCESS FOR THE MANUFACTURE OF GLP-1 ANALOGUES
FRESENIUS KABI IPSUM S R L
Query Match 94.4%Identity 93.5%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAXEFIAWLVRGRG 3129 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020074583-A12020-04-16
- US 11396533-B22022-07-26
-
KR 1020210125880-A2021-10-19
GLP-1 with albumin linked to a specific site
ProAbtech Co., Ltd
Query Match 94.4%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||| ||||||||||||||||| ||| Hit 1 HAEGTFTSDZSSYLEGQAAKEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
JP 2022551233-A2022-12-08
GLP-1 ANALOGUE-MODIFIED DIMERS WITH DIFFERENT CONFIGURATIONS, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN TREATMENT OF TYPE II DIABETES
NANJING FINEPEPTIDE BIOPHARMACEUTICAL CO LTD
Query Match 94.4%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAXEFIAWLVRGRG 3129 of 31 identical, no gaps.
-
EP 1076066-A12001-02-14
Peptides for lowering blood glucose levels
Zealand Pharmaceuticals A/S (DK)
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
WO 0247716-A22002-06-20
Chronic treatment regimen using glucagon-like insulinotropic peptides
ELI LILLY AND COMPANY (US)
Query Match 93.8%Identity 96.7%Family of 5
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- WO 0247716-A22002-06-20
- JP 2004521093-A2004-07-15
- US 7259233-A2007-08-21
- EP 2186824-A22010-05-19
- US 7989585-B22011-08-02
-
KR 1020067018391-A2006-09-08
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
KR 1020067018484-A2006-09-08
Albumin Fusion Proteins
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
WO 2007022123-A22007-02-22
Hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 93.8%Identity 96.7%Family of 6
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
Family of 6
Grouped by the same title and applicant. No priority claim is on record.
- WO 2007022123-A22007-02-22
- JP 2007525495-A2007-09-06
- JP 2011219488-A2011-11-04
- JP 2011246468-A2011-12-08
- EP 2417980-A12012-02-15
- KR 1020140011431-A2014-01-28
-
JP 2007522806-A2007-08-16
Albumin Fusion Proteins
Human Genome Sciences Inc
Query Match 93.8%Identity 96.7%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 60/542274.
- JP 2007522806-A2007-08-16
- JP 2012140448-A2012-07-26
-
JP 2009504681-A2009-02-05
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
ODILE ESTHER LEVY,MICHAEL R HANLEY,CAROLYN M JODKA,DIANA Y LEWIS, CHRISTOPHER J SOARES,SOUMITRA S GHOSH,LAWRENCE J D'SOUZA,DAVID PARKES, CHRISTINE M MACK,B BRUCE FOROOD
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
EP 2171080-A12010-04-07
Methods for detecting protein in plasma
GLAXOSMITHKLINE LLC
Query Match 93.8%Identity 96.7%Family of 2
Best alignment and family
Query 1 to 30, hit 2 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 2 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3129 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2171080-A12010-04-07
- US 8835381-B22014-09-16
-
EP 2214700-A12010-08-11
Semi-synthetic glp-1 peptide-fc fusion constructs, methods and uses
CENTOCOR ORTHO BIOTECH INC
Query Match 93.8%Identity 96.7%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2214700-A12010-08-11
- JP 2011503000-A2011-01-27
-
JP 2010530962-A2010-09-16
Methods for Detecting Protein in Plasma
Charles Scott HOTTENSTEIN,David Richard CITERONE,Jonathan R KEHLER
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 2 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 2 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3129 of 30 identical, no gaps.
-
US 8076288-B22011-12-13
Hybrid polypeptides having glucose lowering activity
Amylin Pharmaceuticals, Inc.
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
US 8202837-B22012-06-19
Methods for administering hypoglycemic agents
GlaxoSmithKline LLC
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
KR 1020130103190-A2013-09-23
Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
Hanmi Science Co., Ltd
Query Match 93.8%Identity 96.8%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||| ||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEPIAWLVKGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020130103190-A2013-09-23
- JP 2015510880-A2015-04-13
- JP 2018009022-A2018-01-18
- JP 2022025114-A2022-02-09
-
KR 1020130111923-A2013-10-11
GLUCAGON SUPERFAMILY PEPTIDES EXHIBITING G PROTEIN-COUPLED RECEPTOR ACTIVITY
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Query Match 93.8%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 ||||||||||||||||||||||| |||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFICWLVKGR 3029 of 30 identical, no gaps.
-
US 8697647-B22014-04-15
Hybrid polypeptides with selectable properties
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2014159431-A2014-09-04
METHODS FOR ADMINISTERING HYPOGLYCEMIC AGENTS
Mark A BUSH,Mary Colleen O'NEILL
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
WO 2014135840-A12014-09-12
NANOPARTICLE PEPTIDE COMPOSITIONS
MIDATECH LTD
Query Match 93.8%Identity 96.7%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2014135840-A12014-09-12
- US 9114082-B22015-08-25
- KR 1020160011618-A2016-02-01
-
US 9453063-B22016-09-27
Hybrid polypeptides with selectable properties
Amylin Pharmaceuticals, LLC. and AstraZeneca Pharmaceuticals LP
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2020502104-A2020-01-23
PRODUCTION OF SELENO-BIOLOGICS IN GENOMICALLY RECODED ORGANISMS
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM, PRESIDENT AND FELLOWS OF HARVARD COLLEGE,Christopher J GREGG
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
KR 1020200047364-A2020-05-07
A novel polypeptide specifically binding to Human Serum Albumin and uses thereof
Korea Advanced Institute of Science and Technology
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 278 to 307. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 278 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30729 of 30 identical, no gaps.
-
US 11492650-B22022-11-08
Production of seleno-biologics in genomically recoded organisms
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM and PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
JP 2023015347-A2023-01-31
PRODUCTION OF SELENO-BIOLOGICS IN GENOMICALLY RECODED ORGANISMS
Board of Regents, The University of Texas System
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
EP 4626438-A22025-10-08
INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS
PINATA HOLDINGS INC
Query Match 93.8%Identity 96.7%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 4626438-A22025-10-08
- JP 2025540138-A2025-12-11
-
EP 4827936-A12026-10-28
USES OF LIPID NANOPARTICLE COMPOSITIONS
BEIJING JITAI LIFE SCIENCES LTD
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
-
KR 1020047016025-A2004-10-08
TREATMENT OF GASTROPARESIS
Query Match 93.2%Identity 100.0%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
-
JP 2005530732-A2005-10-13
TREATMENT OF GASTROPARESIS
Eli Lilly and Company
Query Match 93.2%Identity 100.0%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
-
WO 2009030774-A12009-03-12
Truncated glp-1 derivatives and their therapeutical use
Novo Nordisk A/S (DK)
Query Match 93.2%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2009030774-A12009-03-12
- JP 2010538049-A2010-12-09
- US 9657079-B22017-05-23
-
JP 2017518049-A2017-07-06
METHODS OF CONSTRUCTING AMINO TERMINAL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Query Match 93.2%Identity 96.6%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||||| | Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGGG 3129 of 31 identical, no gaps.